Report cover image

Global Prescription Arthritis Medications Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 184 Pages
SKU # APRC20553452

Description

Summary

According to APO Research, The global Prescription Arthritis Medications market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prescription Arthritis Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Prescription Arthritis Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Prescription Arthritis Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Prescription Arthritis Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Prescription Arthritis Medications include Boehringer Ingelheim, Horizon Pharma, Amgen, Pfizer, Novartis, Abbott and Regeneron, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prescription Arthritis Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Prescription Arthritis Medications, also provides the sales of main regions and countries. Of the upcoming market potential for Prescription Arthritis Medications, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prescription Arthritis Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Prescription Arthritis Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Prescription Arthritis Medications sales, projected growth trends, production technology, application and end-user industry.

Prescription Arthritis Medications Segment by Company

Boehringer Ingelheim
Horizon Pharma
Amgen
Pfizer
Novartis
Abbott
Regeneron
Prescription Arthritis Medications Segment by Type

Oral
Topical
Prescription Arthritis Medications Segment by Application

Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
Prescription Arthritis Medications Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Arthritis Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prescription Arthritis Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Arthritis Medications.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prescription Arthritis Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prescription Arthritis Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Arthritis Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prescription Arthritis Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

184 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Prescription Arthritis Medications Market Size, 2020 VS 2024 VS 2031
1.3 Global Prescription Arthritis Medications Market Size Estimates and Forecasts (2020-2031)
1.4 Global Prescription Arthritis Medications Sales Estimates and Forecasts (2020-2031)
1.5 Global Prescription Arthritis Medications Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Prescription Arthritis Medications Market Dynamics
2.1 Prescription Arthritis Medications Industry Trends
2.2 Prescription Arthritis Medications Industry Drivers
2.3 Prescription Arthritis Medications Industry Opportunities and Challenges
2.4 Prescription Arthritis Medications Industry Restraints
3 Prescription Arthritis Medications Market by Manufacturers
3.1 Global Prescription Arthritis Medications Revenue by Manufacturers (2020-2025)
3.2 Global Prescription Arthritis Medications Sales by Manufacturers (2020-2025)
3.3 Global Prescription Arthritis Medications Average Sales Price by Manufacturers (2020-2025)
3.4 Global Prescription Arthritis Medications Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Prescription Arthritis Medications Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Prescription Arthritis Medications Manufacturers, Product Type & Application
3.7 Global Prescription Arthritis Medications Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Prescription Arthritis Medications Market CR5 and HHI
3.8.2 Global Top 5 and 10 Prescription Arthritis Medications Players Market Share by Revenue in 2024
3.8.3 2024 Prescription Arthritis Medications Tier 1, Tier 2, and Tier 3
4 Prescription Arthritis Medications Market by Type
4.1 Prescription Arthritis Medications Type Introduction
4.1.1 Oral
4.1.2 Topical
4.2 Global Prescription Arthritis Medications Sales by Type
4.2.1 Global Prescription Arthritis Medications Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Prescription Arthritis Medications Sales by Type (2020-2031)
4.2.3 Global Prescription Arthritis Medications Sales Market Share by Type (2020-2031)
4.3 Global Prescription Arthritis Medications Revenue by Type
4.3.1 Global Prescription Arthritis Medications Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Prescription Arthritis Medications Revenue by Type (2020-2031)
4.3.3 Global Prescription Arthritis Medications Revenue Market Share by Type (2020-2031)
5 Prescription Arthritis Medications Market by Application
5.1 Prescription Arthritis Medications Application Introduction
5.1.1 Online Pharmacies
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.2 Global Prescription Arthritis Medications Sales by Application
5.2.1 Global Prescription Arthritis Medications Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Prescription Arthritis Medications Sales by Application (2020-2031)
5.2.3 Global Prescription Arthritis Medications Sales Market Share by Application (2020-2031)
5.3 Global Prescription Arthritis Medications Revenue by Application
5.3.1 Global Prescription Arthritis Medications Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Prescription Arthritis Medications Revenue by Application (2020-2031)
5.3.3 Global Prescription Arthritis Medications Revenue Market Share by Application (2020-2031)
6 Global Prescription Arthritis Medications Sales by Region
6.1 Global Prescription Arthritis Medications Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Prescription Arthritis Medications Sales by Region (2020-2031)
6.2.1 Global Prescription Arthritis Medications Sales by Region (2020-2025)
6.2.2 Global Prescription Arthritis Medications Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Prescription Arthritis Medications Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Prescription Arthritis Medications Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Prescription Arthritis Medications Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Prescription Arthritis Medications Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Prescription Arthritis Medications Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Prescription Arthritis Medications Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Prescription Arthritis Medications Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Prescription Arthritis Medications Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Prescription Arthritis Medications Revenue by Region
7.1 Global Prescription Arthritis Medications Revenue by Region
7.1.1 Global Prescription Arthritis Medications Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Prescription Arthritis Medications Revenue by Region (2020-2025)
7.1.3 Global Prescription Arthritis Medications Revenue by Region (2026-2031)
7.1.4 Global Prescription Arthritis Medications Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Prescription Arthritis Medications Revenue (2020-2031)
7.2.2 North America Prescription Arthritis Medications Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Prescription Arthritis Medications Revenue (2020-2031)
7.3.2 Europe Prescription Arthritis Medications Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Prescription Arthritis Medications Revenue (2020-2031)
7.4.2 Asia-Pacific Prescription Arthritis Medications Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Prescription Arthritis Medications Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Prescription Arthritis Medications Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Boehringer Ingelheim
8.1.1 Boehringer Ingelheim Comapny Information
8.1.2 Boehringer Ingelheim Business Overview
8.1.3 Boehringer Ingelheim Prescription Arthritis Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Boehringer Ingelheim Prescription Arthritis Medications Product Portfolio
8.1.5 Boehringer Ingelheim Recent Developments
8.2 Horizon Pharma
8.2.1 Horizon Pharma Comapny Information
8.2.2 Horizon Pharma Business Overview
8.2.3 Horizon Pharma Prescription Arthritis Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Horizon Pharma Prescription Arthritis Medications Product Portfolio
8.2.5 Horizon Pharma Recent Developments
8.3 Amgen
8.3.1 Amgen Comapny Information
8.3.2 Amgen Business Overview
8.3.3 Amgen Prescription Arthritis Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Amgen Prescription Arthritis Medications Product Portfolio
8.3.5 Amgen Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Prescription Arthritis Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Prescription Arthritis Medications Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Novartis
8.5.1 Novartis Comapny Information
8.5.2 Novartis Business Overview
8.5.3 Novartis Prescription Arthritis Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Novartis Prescription Arthritis Medications Product Portfolio
8.5.5 Novartis Recent Developments
8.6 Abbott
8.6.1 Abbott Comapny Information
8.6.2 Abbott Business Overview
8.6.3 Abbott Prescription Arthritis Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Abbott Prescription Arthritis Medications Product Portfolio
8.6.5 Abbott Recent Developments
8.7 Regeneron
8.7.1 Regeneron Comapny Information
8.7.2 Regeneron Business Overview
8.7.3 Regeneron Prescription Arthritis Medications Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Regeneron Prescription Arthritis Medications Product Portfolio
8.7.5 Regeneron Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Prescription Arthritis Medications Value Chain Analysis
9.1.1 Prescription Arthritis Medications Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Prescription Arthritis Medications Production Mode & Process
9.2 Prescription Arthritis Medications Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Prescription Arthritis Medications Distributors
9.2.3 Prescription Arthritis Medications Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.